| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |